Format

Send to

Choose Destination
Am J Ophthalmol. 2015 Dec;160(6):1116-1126.e5. doi: 10.1016/j.ajo.2015.09.009. Epub 2015 Sep 12.

The Incidence of Trilateral Retinoblastoma: A Systematic Review and Meta-Analysis.

Author information

1
Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands. Electronic address: mc.dejong@vumc.nl.
2
Department of Pediatric Oncology, VU University Medical Center, Amsterdam, Netherlands.
3
Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands.
4
Department of Ophthalmology, VU University Medical Center, Amsterdam, Netherlands.
5
Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Abstract

PURPOSE:

To estimate the incidence of trilateral retinoblastoma in patients with retinoblastoma.

DESIGN:

Systematic review and meta-analysis.

METHODS:

We searched Medline and Embase for scientific literature published between January 1966 and July 2015 that assessed trilateral retinoblastoma incidence. We used a random-effects model for the statistical analyses.

RESULTS:

We included 23 retinoblastoma cohorts from 26 studies. For patients with bilateral retinoblastoma the unadjusted chance of developing trilateral retinoblastoma across all cohorts was 5.3% (95% confidence interval [CI]: 3.3%-7.7%); the chance of pineal trilateral retinoblastoma was 4.2% (95% CI: 2.6%-6.2%) and the chance of nonpineal trilateral retinoblastoma was 0.8% (95% CI: 0.4%-1.3%). In patients with hereditary retinoblastoma (all bilateral cases, and the unilateral cases with a family history or germline RB1 mutation) we found a trilateral retinoblastoma incidence of 4.1% (95% CI: 1.9%-7.1%) and a pineal trilateral retinoblastoma incidence of 3.7% (95% CI: 1.8%-6.2%). To reduce the risk of overestimation bias we restricted analysis to retinoblastoma cohorts with a minimum size of 100 patients, resulting in adjusted incidences of 3.8% (95% CI: 2.4%-5.4%), 2.9% (95% CI: 1.9%-4.2%), and 0.7% (95% CI: 0.3%-1.2%) for any, pineal, and nonpineal trilateral retinoblastoma, respectively, among patients with bilateral retinoblastoma. Among hereditary retinoblastoma we found an adjusted trilateral retinoblastoma incidence of 3.5% (95% CI: 1.2%-6.7%) and a pineal trilateral retinoblastoma incidence of 3.2% (95% CI: 1.4%-5.6%).

CONCLUSION:

The estimated incidence of trilateral retinoblastoma is lower than what is reported in previous literature, especially after exclusion of small cohorts that were subject to overestimation bias in this context.

PMID:
26374932
DOI:
10.1016/j.ajo.2015.09.009
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center